CHD exerts higher burden on men than women

CHD exerts higher burden on men than women

The findings from business intelligence provider GBI Research, finds that while both men and women suffer from specific heart conditions, such as peripheral arterial disease and aortic disease, including aneurysm, CHD tends to have more serious outcomes in men.

According to the company’s latest CBR Pharma report, heart disease is the leading cause of death in men. Around one in five men in the UK die from the condition, which currently affects an estimated 1.6 million of the country’s male population. Lifestyle factors, such as obesity, diet, alcohol consumption and activity levels, tend to be worse in men, leading to a higher incidence of CHD, states the report.

After the age of around 20, cholesterol levels increase more sharply in men than in women. High-density cholesterol levels are reported to correlate closely and inversely with the risk of CHD and are lower in men than women from young adulthood onwards. This is aggravated by the fact that men are 22% more likely to have neglected their cholesterol tests, according to the US Agency for Healthcare Research and Quality.

Indeed, men are 28% more likely than women to be hospitalised for congestive heart failure and stroke is 33% more frequent in male patients. However, this higher incidence of stroke in men has led to a greater awareness of the issue, resulting in improved outcomes for those who suffer a stroke.There is also evidence to suggest that among male CHD patients, mortality doubles in those with low testosterone levels compared to those with normal levels.

Despite this, the CBR Pharma report adds that men are generally less aware about their own health and do not seek health advice or treatment as early as women, preferring to wait until symptoms are unmanageable. This can have serious implications for prognosis and outcomes, they say. 

* Men’s Health – Changing Male Attitudes to Health to Improve Prognosis and Outcomes. CBR Pharma Insights, 2015.

By Jo Carlowe, 

OnMedica, Wednesday 22 April 2015 

View this article